GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 205 filers reported holding GENMAB A/S in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $518,748 | -23.2% | 13,738 | -13.8% | 0.16% | -28.5% |
| Q4 2022 | $675,791 | +14.2% | 15,946 | -13.5% | 0.23% | -3.0% |
| Q3 2022 | $592,000 | -1.7% | 18,430 | -0.6% | 0.24% | +7.8% |
| Q2 2022 | $602,000 | -16.0% | 18,550 | -6.4% | 0.22% | +11.8% |
| Q1 2022 | $717,000 | -19.3% | 19,820 | -11.9% | 0.20% | -17.7% |
| Q4 2021 | $889,000 | -9.8% | 22,490 | -0.3% | 0.24% | -18.0% |
| Q3 2021 | $986,000 | +9.0% | 22,564 | +1.9% | 0.29% | +9.5% |
| Q2 2021 | $905,000 | +92.1% | 22,150 | +54.7% | 0.26% | +63.0% |
| Q1 2021 | $471,000 | -33.5% | 14,320 | -17.7% | 0.16% | -39.3% |
| Q4 2020 | $708,000 | +21.4% | 17,400 | +9.4% | 0.27% | -2.2% |
| Q3 2020 | $583,000 | +131.3% | 15,900 | +113.4% | 0.27% | +129.4% |
| Q2 2020 | $252,000 | – | 7,450 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |